KalVista hits regulatory progress on HAE trial; Elixiron raises $27M in Series A
23 Aug 2021 //
ENDPTS
Elixiron secures $27M to bankroll Alzheimer`s, vitiligo trials
23 Aug 2021 //
FIERCEBIOTECH
23 Aug 2021 //
ENDPTS
23 Aug 2021 //
FIERCEBIOTECH